Does folate deficiency impair red-cell maturation and lower hemoglobin?

Folate is a crucial coenzyme in cellular replication, and its deficiency profoundly disrupts hematopoiesis within the bone marrow.

Cellular and molecular mechanisms

• Impaired DNA synthesis: Folate deficiency limits the availability of 5,10-methylene-tetrahydrofolate, restricting de novo purine and thymidylate (dTMP) synthesis from deoxyuridylate (dUMP) via thymidylate synthase.
• Replication stress: Lacking sufficient thymidylate, rapidly dividing erythroid progenitor cells experience dUTP misincorporation and severe replication stress, which directly halts DNA synthesis.
• Nuclear-cytoplasmic asynchrony: While nuclear replication is stalled, RNA translation, cytoplasmic growth, and hemoglobinization continue uninterrupted, causing a profound developmental mismatch during erythropoiesis.

Pathophysiological consequences

• Macrocytosis: This asynchronous maturation creates abnormally enlarged, megaloblastic precursors. These enter the bloodstream as macro-ovalocytes, manifesting clinically as macrocytosis with an elevated mean corpuscular volume (MCV).
• Ineffective erythropoiesis: Rather than maturing into functional red blood cells, these replication-stressed, megaloblastic precursors undergo S-phase arrest and intrinsic, intramedullary apoptosis.
• Lower hemoglobin: The premature destruction of erythroid precursors within the bone marrow prevents them from reaching the reticulocyte stage, reducing mature red blood cell output and directly lowering overall hemoglobin.

Bottom line

• Folate deficiency impairs dTMP synthesis and halts DNA replication in erythroid precursors. This arrests nuclear maturation while cytoplasmic growth continues, driving both macrocytosis and lower hemoglobin levels via asynchronous maturation and precursor apoptosis.